CRISPR-Cas9 Genome Editing: Applications and Ethical Implications in Human Medicine

Abstract

With its accurate, efficient, and cost-effective genome editing capabilities, CRISPR-Cas9 has revolutionized biomedical research and clinical applications, making it a game-changer in molecular biology. Correction of monogenic disorders like sickle cell anemia and cystic fibrosis, development of innovative cancer immunotherapies, and creation of models for researching complicated diseases are just a few of the many areas where it could be useful in human medicine. In addition, by allowing targeted interventions that are matched to individual genetic profiles, CRISPR-based diagnostics and therapeutic techniques are speeding up the transition toward personalized medicine. Deep social, legal, and ethical questions emerge, though, in tandem with these innovations. Concerns about germline editing, off-target mutations, long-term safety, and unexpected ecological repercussions are major obstacles in the field of science. Strong regulatory frameworks are necessary to resolve the ethical disputes that surround human enhancement, fair access, and the possibility of its abuse for reasons other than treatment. Transparent policies, public involvement, and international consensus are necessary for balancing innovation with responsibility and ensuring the safe and ethical application of CRISPR technologies. The fast adoption of CRISPR-Cas9 and its revolutionary uses in human health raise important ethical challenges, highlighting the need to balance scientific advancement with society values.